272 related articles for article (PubMed ID: 6321070)
1. Epstein-Barr serology in immunodeficiencies: an attempt to correlate with immune abnormalities in Wiskott-Aldrich and Chediak-Higashi syndromes and ataxia telangiectasia.
Vilmer E; Lenoir GM; Virelizier JL; Griscelli C
Clin Exp Immunol; 1984 Feb; 55(2):249-56. PubMed ID: 6321070
[TBL] [Abstract][Full Text] [Related]
2. Immune response to Epstein-Barr virus (EBV) in ataxia-telangiectasia: EBV-specific antibody patterns and their relation to cell-mediated immunity.
Berkel AI; Henle W; Henle G; Ersoy F; Sanal O; Klein G; Yeğin O
Kroc Found Ser; 1985; 19():287-300. PubMed ID: 2999343
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus antibodies in patients with ataxia-telangiectasia and other immunodeficiency diseases.
Joncas JH; Wills A; Reece E; Fox Z
Can Med Assoc J; 1981 Oct; 125(8):845-9. PubMed ID: 6272957
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus-related antibody patterns in ataxia-telangiectasia.
Berkel AI; Henle W; Henle G; Klein G; Ersoy F; Sanal O
Clin Exp Immunol; 1979 Feb; 35(2):196-201. PubMed ID: 219976
[TBL] [Abstract][Full Text] [Related]
5. [Studies on Epstein-Barr virus (EBV) infection and reactivity of peripheral B lymphocytes to EBV in patients with ataxia telangiectasia].
Okano M
Hokkaido Igaku Zasshi; 1986 Jul; 61(4):584-92. PubMed ID: 3019855
[TBL] [Abstract][Full Text] [Related]
6. Elevated antibody titers to Epstein-Barr virus and low natural killer cell activity in patients with Chediak-Higashi syndrome.
Merino F; Klein GO; Henle W; Ramirez-Duque P; Forsgren M; Amesty C
Clin Immunol Immunopathol; 1983 Jun; 27(3):326-39. PubMed ID: 6307571
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus infection and oncogenesis in primary immunodeficiency.
Okano M; Osato T; Koizumi S; Imai S; Aya T; Fujiwara S; Mizuno F; Sakiyama Y; Matsumoto S; Sugawara O
AIDS Res; 1986 Dec; 2 Suppl 1():S115-9. PubMed ID: 3030341
[TBL] [Abstract][Full Text] [Related]
8. [Immunological deficiencies].
De Sousa Pinto JM
Arq Patol; 1974; 46(2-3):287-98. PubMed ID: 4458642
[No Abstract] [Full Text] [Related]
9. In vivo Epstein Barr virus-induced augmentation of natural killer cell activity in the Chédiak-Higashi syndrome.
Katz P; Zaytoun AM; Lee JH; Fauci AS
J Immunol; 1984 Feb; 132(2):571-3. PubMed ID: 6197464
[No Abstract] [Full Text] [Related]
10. [Epstein-Barr virus infection and immune responses in primary immunodeficiency syndromes].
Sakiyama Y
Hokkaido Igaku Zasshi; 1984 Jul; 59(4):379-82. PubMed ID: 6092247
[No Abstract] [Full Text] [Related]
11. The "lazy" NK cells of Chediak-Higashi syndrome.
Targan SR; Oseas R
J Immunol; 1983 Jun; 130(6):2671-4. PubMed ID: 6602174
[TBL] [Abstract][Full Text] [Related]
12. Chediak-Higashi syndrome: immunological responses to Epstein-Barr virus studies in gene heterozygotes.
Merino F; Amesty C; Henle W; Layrisse Z; Bianco N; Ramírez-Duque P
J Clin Immunol; 1986 May; 6(3):242-8. PubMed ID: 3013924
[TBL] [Abstract][Full Text] [Related]
13. Infections in the compromised host.
Hughes WT
Adv Intern Med; 1977; 22():73-96. PubMed ID: 320849
[No Abstract] [Full Text] [Related]
14. Epstein-Barr virus (EBV)-specific cell-mediated and humoral immune responses in ataxia-telangectasia patients.
Masucci G; Berkel I; Masucci MG; Ernberg I; Szigeti R; Ersoy F; Sanal O; Yegin O; Henle G; Henle W
J Clin Immunol; 1984 Sep; 4(5):369-82. PubMed ID: 6092413
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus infections in hairy cell leukemia patients in the presence of complement-dependent neutralizing antibody.
Sairenji T; Sullivan JL; Sakamoto K; Spiro RC; Katayama I; Humphreys RE
Cancer Res; 1985 Jan; 45(1):411-5. PubMed ID: 2981160
[TBL] [Abstract][Full Text] [Related]
16. [Lymphoid subpopulations in immunodeficiencies. Case reports].
Diez RA; Sen L; Estevez ME; Giuntoli J
Medicina (B Aires); 1981; 41 Suppl():147-54. PubMed ID: 7345339
[No Abstract] [Full Text] [Related]
17. Herpesvirus saimiri-transformed CD8+ T cells as a tool to study Chediak-Higashi syndrome cytolytic lymphocytes.
Martín-Fernández JM; Cabanillas JA; Rivero-Carmena M; Lacasa E; Pardo J; Anel A; Ramírez-Duque PR; Merino F; Rodríguez-Gallego C; Regueiro JR
J Leukoc Biol; 2005 May; 77(5):661-8. PubMed ID: 15728247
[TBL] [Abstract][Full Text] [Related]
18. Further studies of natural killer cell function in Chediak-Higashi patients.
Roder JC; Haliotis T; Laing L; Kozbor D; Rubin P; Pross H; Boxer LA; White JG; Fauci AS; Mostowski H; Matheson DS
Immunology; 1982 Jul; 46(3):555-60. PubMed ID: 6212535
[TBL] [Abstract][Full Text] [Related]
19. Unusual prevalence of Epstein-Barr virus early antigen (EBV-EA) antibodies in ataxia telangiectasia.
Joncas J; Lapointe N; Gervais F; Leyritz M
J Immunol; 1977 Nov; 119(5):1857-9. PubMed ID: 199670
[No Abstract] [Full Text] [Related]
20. A familial syndrome of susceptibility to chronic active Epstein-Barr virus infection.
Joncas JH; Ghibu F; Blagdon M; Montplaisir S; Stefanescu I; Menezes J
Can Med Assoc J; 1984 Feb; 130(3):280-4. PubMed ID: 6318944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
